UCSF

ZINC02570895

Substance Information

In ZINC since Heavy atoms Benign functionality
October 27th, 2004 26 Yes

Other Names:

coxib

169590-42-5

169590-42-5; C07589; Celecoxib

169590-42-5; Celebrex (TN); Celecoxib (JAN/USAN/INN); D00567

169590-42-5; CPD000550473; Celecoxib; SAM002589995

184007-95-2

1oq5

4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide

4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide; Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-; Benzenesulfonamide

4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide

4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE

4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide

4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide

4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

AC-4228

AC1L1E6K

AI-525

Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-

benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-

Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)

BIDD:GT0408

BRD-K02637541-001-02-4

BSPBio_003596

C07589

C105934

C17H14F3N3O2S

CCRIS 8679

CEL

Celebra

Celebrex

Celebrex (TN)

Celebrex, Celebra

Celebrex, Celebra, Celecoxib

Celebrex; Celecoxib; Celocoxib

Celebrex;Celecoxib;Celocoxib

Celecox

Celecoxi

Celecoxib

Celecoxib (BAN

Celecoxib (JAN/USAN/INN)

Celecoxib (SC-58635)

Celecoxib [Old RN]

Celecoxib [USAN]

celecoxib; celecoxibum

Celocoxib

CEP-33222

CHEBI:41418; CHEBI:3520

CHEBI:41423

CHEMBL118

CID2662

cMAP_000027

CPD000550473

CPD000550473; Celecoxib; SAM002589995

D00567

DAP000737

DB00482

DivK1c_000893

Eurocox

FDA

FT-0080064

HMS1922G14

HMS2089L18

HMS2093I07

HMS502M15

HSDB 7038

I01-1033

IDI1_000893

INN

KBio1_000893

KBio2_000912

KBio2_002351

KBio2_003480

KBio2_004919

KBio2_006048

KBio2_007487

KBio3_002830

KBio3_003037

KBioGR_000723

KBioGR_002351

KBioSS_000912

KBioSS_002354

LS-31667

Medicoxib

METHYLPHENYLTRIFLUOROMETHYLPYRAZOLYLBENZENESULFONAMID

MFCD00941298

MLS001165684

MLS001195656

MLS001304708

MolPort-002-885-815

NCGC00091455-01

NCGC00091455-02

NCGC00091455-03

NCGC00091455-04

NCI60_041049

NINDS_000893

NSC719627

Onsenal

p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide

Pfizer brand of celecoxib

S1261_Selleck

SAM002589995

SC 58635

SC-58553, SC-58635

SC-58635

SC58635

SMR000550473

Solexa

SPBio_001512

SPECTRUM1503678

Spectrum2_001576

Spectrum3_001996

Spectrum4_000182

Spectrum5_001324

Spectrum_000432

TL8001323

TPI-336

UNM-0000305813

USAN)

Xilebao

YM 177

YM-177

YM177

ZINC02570895

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.61 5.33 -11.94 2 5 0 78 381.379 4

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 5.03e-03 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Purity 98% Matrix Scientific
biological_use Also used in the treatment of familial adenomatous polyposis IBScreen Bioactives
Indications analgesic, NSAID KeyOrganics Bioactives
Therapy antiarthritic, cyclooxygenase2 inhibitor SMDC Iconix
Target COX Selleck Chemicals
mechanism Cyclooxygenase-2 (COX-2) inhibitor IBScreen Bioactives
Patent Database Links EP1064948; EP1064964; EP1088550; EP1167355; EP1405646; EP1471054; EP1498140; EP1518555; EP1525883; EP1528058; EP1537858; EP1538164; EP1547650; EP1593386; EP1602334; EP1611877; EP1627639; EP1629835; EP1637137; EP1640003; EP1661560; EP1698330; EP1712220; EP ChEBI
biological_use Inhibits colon carcinogenesis in animal models IBScreen Bioactives
Warnings IRRITANT Matrix Scientific
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : C-3950; NCC_SUPPLIER_SAMPLE_COMMENTS : YELLOW CRISTALLINE POWDER NIH Clinical Collection via PubChem
biological_use Non-steroidal antiinflammatory drug IBScreen Bioactives IBScreen Bioactives
Reactome Database Links REACT_150255 ChEBI
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: C-3950; SUPPLIER_COMMENTS: YELLOW CRISTALLINE POWDER NIH Clinical Collection via PubChem
UniProt Database Links STK11_MOUSE ChEBI
biological_use Used in the treatment of rheumatoid arthritis and osteoarthritis IBScreen Bioactives

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
CAH-1-A Carbonic Anhydrase (cluster #1 Of 2), Archaea Archaea 140 0.37 Binding ≤ 10μM
CYNT-1-B Carbonic Anhydrase (cluster #1 Of 3), Bacterial Bacteria 713 0.33 Binding ≤ 10μM
B5SU02-2-E Alpha Carbonic Anhydrase (cluster #2 Of 6), Eukaryotic Eukaryotes 34 0.40 Binding ≤ 10μM
C0IX24-1-E Carbonic Anhydrase (cluster #1 Of 5), Eukaryotic Eukaryotes 690 0.33 Binding ≤ 10μM
CAH12-1-E Carbonic Anhydrase XII (cluster #1 Of 9), Eukaryotic Eukaryotes 18 0.42 Binding ≤ 10μM
CAH13-1-E Carbonic Anhydrase XIII (cluster #1 Of 7), Eukaryotic Eukaryotes 98 0.38 Binding ≤ 10μM
CAH14-1-E Carbonic Anhydrase XIV (cluster #1 Of 8), Eukaryotic Eukaryotes 689 0.33 Binding ≤ 10μM
CAH15-2-E Carbonic Anhydrase 15 (cluster #2 Of 6), Eukaryotic Eukaryotes 45 0.40 Binding ≤ 10μM
CAH2-1-E Carbonic Anhydrase II (cluster #1 Of 15), Eukaryotic Eukaryotes 21 0.41 Binding ≤ 10μM
CAH4-1-E Carbonic Anhydrase IV (cluster #1 Of 16), Eukaryotic Eukaryotes 290 0.35 Binding ≤ 10μM
CAH5A-1-E Carbonic Anhydrase VA (cluster #1 Of 10), Eukaryotic Eukaryotes 794 0.33 Binding ≤ 10μM
CAH5B-1-E Carbonic Anhydrase VB (cluster #1 Of 9), Eukaryotic Eukaryotes 93 0.38 Binding ≤ 10μM
CAH6-2-E Carbonic Anhydrase VI (cluster #2 Of 8), Eukaryotic Eukaryotes 94 0.38 Binding ≤ 10μM
CAH7-1-E Carbonic Anhydrase VII (cluster #1 Of 8), Eukaryotic Eukaryotes 2170 0.30 Binding ≤ 10μM
CAH9-1-E Carbonic Anhydrase IX (cluster #1 Of 11), Eukaryotic Eukaryotes 16 0.42 Binding ≤ 10μM
COX2-1-E Cytochrome C Oxidase Subunit 2 (cluster #1 Of 1), Eukaryotic Eukaryotes 60 0.39 Binding ≤ 10μM
MK14-1-E MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic Eukaryotes 810 0.33 Binding ≤ 10μM
PGH1-1-E Cyclooxygenase-1 (cluster #1 Of 6), Eukaryotic Eukaryotes 9730 0.27 Binding ≤ 10μM
PGH2-4-E Cyclooxygenase-2 (cluster #4 Of 8), Eukaryotic Eukaryotes 9 0.43 Binding ≤ 10μM
Q8HZR1-1-E Cyclooxygenase-1 (cluster #1 Of 1), Eukaryotic Eukaryotes 5570 0.28 Binding ≤ 10μM
Q8SPQ9-2-E Cyclooxygenase-2 (cluster #2 Of 2), Eukaryotic Eukaryotes 900 0.33 Binding ≤ 10μM
CAH2-1-E Carbonic Anhydrase II (cluster #1 Of 2), Eukaryotic Eukaryotes 21 0.41 Functional ≤ 10μM
CAH4-1-E Carbonic Anhydrase IV (cluster #1 Of 2), Eukaryotic Eukaryotes 290 0.35 Functional ≤ 10μM
PGH1-1-E Cyclooxygenase-1 (cluster #1 Of 2), Eukaryotic Eukaryotes 2000 0.31 Functional ≤ 10μM
PGH2-1-E Cyclooxygenase-2 (cluster #1 Of 1), Eukaryotic Eukaryotes 3600 0.29 Functional ≤ 10μM
CP2C9-1-E Cytochrome P450 2C9 (cluster #1 Of 3), Eukaryotic Eukaryotes 10000 0.27 ADME/T ≤ 10μM
CAN-1-F Carbonic Anhydrase (cluster #1 Of 3), Fungal Fungi 108 0.38 Binding ≤ 10μM
Q5AJ71-1-F Carbonic Anhydrase (cluster #1 Of 4), Fungal Fungi 21 0.41 Binding ≤ 10μM
Z100741-1-O MC9 (Mast Cells) (cluster #1 Of 2), Other Other 400 0.34 Functional ≤ 10μM
Z50587-1-O Homo Sapiens (cluster #1 Of 9), Other Other 6670 0.28 Functional ≤ 10μM
Z80548-1-O THP-1 (Acute Monocytic Leukemia Cells) (cluster #1 Of 5), Other Other 5000 0.29 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
B5SU02_9CNID B5SU02 Alpha Carbonic Anhydrase, 9cnid 34.2 0.40 Binding ≤ 1μM
CAH_METTE P40881 Carbonic Anhydrase, Mette 140 0.37 Binding ≤ 1μM
CYNT_MYCTU O53573 Carbonic Anhydrase, Myctu 713 0.33 Binding ≤ 1μM
C0IX24_9CNID C0IX24 Carbonic Anhydrase, 9cnid 690 0.33 Binding ≤ 1μM
Q5AJ71_CANAL Q5AJ71 Carbonic Anhydrase, Canal 21 0.41 Binding ≤ 1μM
CAN_YEAST P53615 Carbonic Anhydrase, Yeast 108 0.38 Binding ≤ 1μM
CAH15_MOUSE Q99N23 Carbonic Anhydrase 15, Mouse 45 0.40 Binding ≤ 1μM
CAH2_HUMAN P00918 Carbonic Anhydrase II, Human 21 0.41 Binding ≤ 1μM
CAH4_BOVIN Q95323 Carbonic Anhydrase IV, Bovin 290 0.35 Binding ≤ 1μM
CAH4_HUMAN P22748 Carbonic Anhydrase IV, Human 880 0.33 Binding ≤ 1μM
CAH9_HUMAN Q16790 Carbonic Anhydrase IX, Human 16 0.42 Binding ≤ 1μM
CAH5A_HUMAN P35218 Carbonic Anhydrase VA, Human 794 0.33 Binding ≤ 1μM
CAH5B_HUMAN Q9Y2D0 Carbonic Anhydrase VB, Human 93 0.38 Binding ≤ 1μM
CAH6_HUMAN P23280 Carbonic Anhydrase VI, Human 94 0.38 Binding ≤ 1μM
CAH12_HUMAN O43570 Carbonic Anhydrase XII, Human 18 0.42 Binding ≤ 1μM
CAH13_HUMAN Q8N1Q1 Carbonic Anhydrase XIII, Human 98 0.38 Binding ≤ 1μM
CAH14_HUMAN Q9ULX7 Carbonic Anhydrase XIV, Human 689 0.33 Binding ≤ 1μM
PGH1_HUMAN P23219 Cyclooxygenase-1, Human 3.54 0.46 Binding ≤ 1μM
PGH1_MOUSE P22437 Cyclooxygenase-1, Mouse 0.7 0.49 Binding ≤ 1μM
PGH1_SHEEP P05979 Cyclooxygenase-1, Sheep 210 0.36 Binding ≤ 1μM
PGH2_HUMAN P35354 Cyclooxygenase-2, Human 0.519995997 0.50 Binding ≤ 1μM
Q8SPQ9_CANFA Q8SPQ9 Cyclooxygenase-2, Canine 900 0.33 Binding ≤ 1μM
PGH2_MOUSE Q05769 Cyclooxygenase-2, Mouse 0.51 0.50 Binding ≤ 1μM
PGH2_SHEEP P79208 Cyclooxygenase-2, Sheep 100 0.38 Binding ≤ 1μM
PGH2_BOVIN O62698 Cyclooxygenase-2, Bovin 57 0.39 Binding ≤ 1μM
COX2_SHEEP O78750 Cytochrome C Oxidase Subunit 2, Sheep 60 0.39 Binding ≤ 1μM
MK14_HUMAN Q16539 MAP Kinase P38 Alpha, Human 810 0.33 Binding ≤ 1μM
B5SU02_9CNID B5SU02 Alpha Carbonic Anhydrase, 9cnid 34.2 0.40 Binding ≤ 10μM
Q5AJ71_CANAL Q5AJ71 Carbonic Anhydrase, Canal 1017 0.32 Binding ≤ 10μM
C0IX24_9CNID C0IX24 Carbonic Anhydrase, 9cnid 690 0.33 Binding ≤ 10μM
CAN_YEAST P53615 Carbonic Anhydrase, Yeast 108 0.38 Binding ≤ 10μM
CAH_METTE P40881 Carbonic Anhydrase, Mette 1010 0.32 Binding ≤ 10μM
CYNT_MYCTU O53573 Carbonic Anhydrase, Myctu 713 0.33 Binding ≤ 10μM
CAH15_MOUSE Q99N23 Carbonic Anhydrase 15, Mouse 45 0.40 Binding ≤ 10μM
CAH2_HUMAN P00918 Carbonic Anhydrase II, Human 21 0.41 Binding ≤ 10μM
CAH4_HUMAN P22748 Carbonic Anhydrase IV, Human 880 0.33 Binding ≤ 10μM
CAH4_BOVIN Q95323 Carbonic Anhydrase IV, Bovin 290 0.35 Binding ≤ 10μM
CAH9_HUMAN Q16790 Carbonic Anhydrase IX, Human 16 0.42 Binding ≤ 10μM
CAH5A_HUMAN P35218 Carbonic Anhydrase VA, Human 794 0.33 Binding ≤ 10μM
CAH5B_HUMAN Q9Y2D0 Carbonic Anhydrase VB, Human 93 0.38 Binding ≤ 10μM
CAH6_HUMAN P23280 Carbonic Anhydrase VI, Human 94 0.38 Binding ≤ 10μM
CAH7_HUMAN P43166 Carbonic Anhydrase VII, Human 2170 0.30 Binding ≤ 10μM
CAH12_HUMAN O43570 Carbonic Anhydrase XII, Human 18 0.42 Binding ≤ 10μM
CAH13_HUMAN Q8N1Q1 Carbonic Anhydrase XIII, Human 98 0.38 Binding ≤ 10μM
CAH14_HUMAN Q9ULX7 Carbonic Anhydrase XIV, Human 689 0.33 Binding ≤ 10μM
Q8HZR1_CANFA Q8HZR1 Cyclooxygenase-1, Canine 5570 0.28 Binding ≤ 10μM
PGH1_HUMAN P23219 Cyclooxygenase-1, Human 1689 0.31 Binding ≤ 10μM
PGH1_MOUSE P22437 Cyclooxygenase-1, Mouse 0.7 0.49 Binding ≤ 10μM
PGH1_SHEEP P05979 Cyclooxygenase-1, Sheep 210 0.36 Binding ≤ 10μM
PGH1_BOVIN O62664 Cyclooxygenase-1, Bovin 7700 0.28 Binding ≤ 10μM
PGH2_MOUSE Q05769 Cyclooxygenase-2, Mouse 0.51 0.50 Binding ≤ 10μM
PGH2_SHEEP P79208 Cyclooxygenase-2, Sheep 100 0.38 Binding ≤ 10μM
PGH2_BOVIN O62698 Cyclooxygenase-2, Bovin 57 0.39 Binding ≤ 10μM
Q8SPQ9_CANFA Q8SPQ9 Cyclooxygenase-2, Canine 900 0.33 Binding ≤ 10μM
PGH2_RAT P35355 Cyclooxygenase-2, Rat 1100 0.32 Binding ≤ 10μM
PGH2_HUMAN P35354 Cyclooxygenase-2, Human 0.519995997 0.50 Binding ≤ 10μM
COX2_SHEEP O78750 Cytochrome C Oxidase Subunit 2, Sheep 60 0.39 Binding ≤ 10μM
MK14_HUMAN Q16539 MAP Kinase P38 Alpha, Human 810 0.33 Binding ≤ 10μM
CAH2_HUMAN P00918 Carbonic Anhydrase II, Human 21 0.41 Functional ≤ 10μM
CAH4_BOVIN Q95323 Carbonic Anhydrase IV, Bovin 290 0.35 Functional ≤ 10μM
PGH1_HUMAN P23219 Cyclooxygenase-1, Human 1880 0.31 Functional ≤ 10μM
PGH2_HUMAN P35354 Cyclooxygenase-2, Human 110 0.37 Functional ≤ 10μM
Z50587 Z50587 Homo Sapiens 164 0.37 Functional ≤ 10μM
Z100741 Z100741 MC9 (Mast Cells) 300 0.35 Functional ≤ 10μM
Z80548 Z80548 THP-1 (Acute Monocytic Leukemia Cells) 5000 0.29 Functional ≤ 10μM
CP2C9_HUMAN P11712 Cytochrome P450 2C9, Human 10000 0.27 ADME/T ≤ 10μM

Direct Reactome Annotations (via ChEBI)

Description Species
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)

Reactome Annotations from Targets (via Uniprot)

Description Species
activated TAK1 mediates p38 MAPK activation
Activation of PPARGC1A (PGC-1alpha) by phosphorylation
Activation of the AP-1 family of transcription factors
ADP signalling through P2Y purinoceptor 1
CDO in myogenesis
COX reactions
CYP2E1 reactions
DSCAM interactions
ERK/MAPK targets
Erythrocytes take up carbon dioxide and release oxygen
Erythrocytes take up oxygen and release carbon dioxide
KSRP destabilizes mRNA
Nicotinamide salvaging
NOD1/2 Signaling Pathway
Oxidative Stress Induced Senescence
p38MAPK events
Platelet sensitization by LDL
Regulation of gene expression by Hypoxia-inducible Factor
Reversible hydration of carbon dioxide
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)
Synthesis of 15-eicosatetraenoic acid derivatives
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
VEGFA-VEGFR2 Pathway
Xenobiotics

Analogs ( Draw Identity 99% 90% 80% 70% )